Lundbeck, Otsuka collaborate to develop Lu AE58054
As part of the agreement, Otsuka will gain from Lundbeck co-development and co-commercialization rights to Lu AE58054 in the US, Canada, East Asia including Japan, major European countries
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
Manufactured according to appropriate good manufacturing practices (GMP) and stringent quality systems, STA-PURE polytetrafluoroethylene (ePTFE) gasketing products maintain seals that are consistently reliable and meet the FDA requirements
Under the agreement, BioTime will use LifeMap’s computer-based tools to extract information related to novel potential commercial products from approximately 100 million proprietary gene expression data points generated